American Healthcare REIT Files 8-K for Regulation FD Disclosure

TL;DR

**AHR just dropped an 8-K, likely sharing new info that could move the stock.**

AI Summary

American Healthcare REIT, Inc. filed an 8-K on January 11, 2024, primarily under Regulation FD Disclosure, indicating they are making information public that was not previously disclosed. This filing also includes financial statements and exhibits. For investors, this matters because it suggests the company is proactively sharing important, non-public information, which could influence stock valuation or future strategic decisions.

Why It Matters

This filing signals that American Healthcare REIT, Inc. is releasing material non-public information, which could impact investor perception and the stock's future performance.

Risk Assessment

Risk Level: low — This 8-K is a standard disclosure filing and does not inherently present a high risk, but the content of the undisclosed information could be significant.

Analyst Insight

A smart investor would monitor for subsequent announcements or the specific content of the 'Regulation FD Disclosure' to understand the nature of the information being released, as this could significantly impact the company's outlook.

Key Players & Entities

• American Healthcare REIT, Inc. (company) — the registrant filing the 8-K
• January 11, 2024 (date) — date of earliest event reported and filing date
• 000-55775 (string) — Commission File Number
• Maryland (string) — State of incorporation
• 18191 Von Karman Avenue, Suite 300, Irvine, California, 92612 (string) — principal executive offices address

FAQ

Key Financial Figures

• $13.15 — and Class I common stock at a price of $13.15 per share. For several reasons discusse

Filing Documents

• ahr-20240111.htm (8-K) — 29KB
• exhibit991comrittorespon.htm (EX-99.1) — 11KB
• exhibit991comrittorespon001.jpg (GRAPHIC) — 288KB
• exhibit991comrittorespon002.jpg (GRAPHIC) — 282KB
• 0001632970-24-000003.txt ( ) — 945KB
• ahr-20240111.xsd (EX-101.SCH) — 2KB
• ahr-20240111_lab.xml (EX-101.LAB) — 22KB
• ahr-20240111_pre.xml (EX-101.PRE) — 11KB
• ahr-20240111_htm.xml (XML) — 2KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On January 11, 2024, our board of directors issued a response to an unsolicited mini-tender offer from an unaffiliated third party, Comrit Investments 1, Limited Partnership, to purchase up to an aggregate of 228,136 shares of our Class T and Class I common stock at a price of $13.15 per share. For several reasons discussed in the response letter, our board of directors has determined not to make any recommendation and to remain neutral as to whether stockholders should tender shares in the offer. The response letter, addressed to our stockholders and attached to this Form 8-K as Exhibit 99.1, is available on our website in the Investor Relations – Investor Communications section at www.AmericanHealthcareREIT.com and incorporated in its entirety into this Item 7.01. The response letter to stockholders will also be mailed to our stockholders upon their request. The information in this report, including Exhibit 99.1, is being furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 American Healthcare REIT, Inc. Response Letter Re. Comrit Tender Offer dated January 11, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. American Healthcare REIT, Inc. January 11, 2024 By: /s/ Danny Prosky Name: Danny Prosky Title: Chief Executive Officer and President

View Full Filing

View this 8-K filing on SEC EDGAR